Beijing Gese Technology Co.
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $7.9M
Investors
- 2
About Beijing Gese Technology Co.
, Ltd operates as a digital health brand that provides self-discovery tools and tailored solutions for individuals. By decoding each individual’s unique genetic code and life experience, the company is committed to help customers reveal their inherent traits and to support their self-discovery attempts. The company provides users with a dynamic life data management system. It has a set of raw DNA data comprising of 700 000 genetic loci. The company interprets the user's DNA and behaviors with science, and provides solutions with consideration of both inherent inclination and behavior assessments. The company has also published a number of scientific posts of various topics which attract over one million of readers.
Who invested in Beijing Gese Technology Co.
2 investors across 1 round
See all investors in Beijing Gese Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 8, 2022
Amount
$7.9M
Investors
Questions about Beijing Gese Technology Co.
Who invested in Beijing Gese Technology Co.?
Beijing Gese Technology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Gese Technology Co. raised?
Beijing Gese Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beijing Gese Technology Co. last raise money?
Beijing Gese Technology Co.'s most recent round on record is a Series A, in Mar 2022.
What does Beijing Gese Technology Co. do?
, Ltd operates as a digital health brand that provides self-discovery tools and tailored solutions for individuals.
Where is Beijing Gese Technology Co. headquartered?
Beijing Gese Technology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Gese Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Gese Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beijing Gese Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.